Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 30 of 58, showing 10 Applications out of 576 total, starting on record 291, ending on 300

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

291.

ECCT/21/05/07   CoVPN 3008
    Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern   
Principal Investigator(s)
1. Grace Mboya Mugure
Site(s) in Kenya
1. KEMRI CGHR Kisumu Clinical Research Site (Kisumu county)
 
05-08-2021 View

292.

ECCT/21/05/06   VAC52150EBL2010 ;Phase 2
    An open label, Phase 2 study to evaluate the safety and immunogenicity of an Ad26.ZEBOV booster dose in Human Immunodeficiency Virus Positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen   
Principal Investigator(s)
1. Prof. Omu Anzala Omu Anzala
Site(s) in Kenya
KAVI-institute of Clinical Research
 
11-08-2021 View

293.

ECCT/21/05/05   The “EMPATHY” Trial
    A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19.       
Principal Investigator(s)
1. DR LUCAS OTIENO TINA
2. Dr. Bernhards Ragama Ogutu
3. Dr Deborah Chepngeno Langat
4. Dr Videlis Nduba Nduba
5. Dr Janet Oyieko
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Kenyatta University Teaching Referral and Research Hospital (KUTRRH) (Nairobi City county)
3. Kenya Medical Research Institute/US Army Medical Research Directorate-Kenya-Kericho (Kericho county)
4. KEMRI, Centre for Respiratory Diseases Research (CRDR) (Nairobi City county)
5. KEMRI-USAMRD-A, Kisumu Field Station (Kisumu county)
 
11-08-2021 View

294.

ECCT/21/05/04   Multi-nutrients in ADHD
    Broad spectrum micronutrient supplementation in the management of ADHD symptoms:a clinical trial   
Principal Investigator(s)
1. Maureen Muthoni Njoroge
Site(s) in Kenya
Kenyatta National Hospital
 
10-11-2021 View

295.

ECCT/21/05/03   Adapt Out COVID
    Adaptive Platform Treatment trial for Outpatients with COVID-19   
Principal Investigator(s)
1. Kawango Agot
Site(s) in Kenya
1. Kenya Impact and Research Development Organization (K-IRDO) (Kisumu county)
2. KEMRI WALTER REED (Kericho county)
3. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (Uasin Gishu county)
4. Kenya Medical Research Institute (Kisumu county)
 
28-07-2021 View

296.

ECCT/21/05/02   BFTAF Elderly Switch Study
    Switching virally suppressed HIV-1 infected elderly adults (age ≥ 60 years) without prior confirmed virological failure from current anti-retroviral regimen to bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF)   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
04-08-2021 View

297.

ECCT/21/05/01   ZAZA study
    Zinc isotope study: Assessing Zinc absorption from edible insects in young children   
Principal Investigator(s)
1. Dr. Alida Melse-Boonstra Melse-Boonstra
Site(s) in Kenya
Ober-Kamoth sub-county hospital - Level 4 Health Facility
 
31-08-2021 View

298.

ECCT/21/04/01   FujiLAM Study
    Diagnostic performance of a novel lipoarabinomannan test (FujiLAM) to detect tuberculosis in HIV-positive patients in Kenya   
Principal Investigator(s)
1. Helena Huerga
Site(s) in Kenya
Homabay County Teaching and Referral Hospital
 
04-11-2021 View

299.

ECCT/21/03/07   CHIMES
    AN OPEN-LABEL, MULTICENTER STUDY TO ASSESS DISEASE ACTIVITY AND BIOMARKERS OF NEURONAL DAMAGE IN MINORITY PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS RECEIVING TREATMENT WITH OCRELIZUMAB   
Principal Investigator(s)
1. Mansoor Saleh
Site(s) in Kenya
Aga Khan University, Nairobi
 
08-06-2021 View

300.

ECCT/21/03/06   P2026
    Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum   
Principal Investigator(s)
1. Dr. Lucy Chepkurui Koech
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT CLINICAL RESEARCH CENTER
 
07-08-2021 View